NCT02357069View on ClinicalTrials.gov

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

PHASE3UnknownINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2016

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Enbrel

Etanercept

DRUG

LBEC0101

Etanercept

Trial Locations (2)

Unknown

Mochida Investigational site, Tokyo

LGLS Investigational site, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
collaborator

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

lead

LG Life Sciences

INDUSTRY

NCT02357069 - A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy | Biotech Hunter | Biotech Hunter